Compounds and compositions for delivery of therapeutic agents
AssigneeModernaTX, Inc.
InventorsKerry E. BENENATO, Juneyoung LEE, Mohindra SEEPERSAUD
Life of this patent
Estimating the term…
Abstract
The disclosure features novel lipids and compositions involving the same. Lipid nanoparticles (e.g., empty LNPs or loaded LNPs) include a novel cationic lipid as well as additional lipids such as ionizable lipids, phospholipids, structural lipids, and PEG lipids. Lipid nanoparticles (e.g., empty LNPs or loaded LNPs) further including therapeutic and/or prophylactics such as RNA are useful in the delivery of therapeutic and/or prophylactics to mammalian cells or organs to, for example, regulate polypeptide, protein, or gene expression.
Claims55
A cationic lipid of Formula (I):
- or an isomer thereof, wherein:
- R′x is:
- R′y is:
- and R′z is:
- wherein
- denotes a point of attachment;
- Rxα, Rxγ, Rxγ, and Rxδ are each independently selected from the group consisting of H, C1-12 alkyl, and C2-12 alkenyl;
- Ryα, Ryβ, Ryγ, and Ryδ are each independently selected from the group consisting of H, C1-12 alkyl, and C2-12 alkenyl;
- Rzα, Rzβ, Rzγ, and Rzδ are each independently selected from the group consisting of H, C1-12 alkyl, and C2-12 alkenyl;
- RH is —(CH2)qOH, wherein q is selected from 1, 2, 3, 4, and 5;
- each RT is independently selected from C1-12 alkyl and C2-12 alkenyl;
- a is selected from 1, 2, 3, 4, 5, 6, 7, 8, and 9;
- b is selected from 1, 2, 3, 4, 5, 6, 7, 8, and 9;
- c is selected from 1, 2, 3, 4, 5, 6, 7, 8, and 9;
- and
- A− is any pharmaceutically acceptable anion.
The compound of any one of the preceding claims, wherein q is 2.
The compound of any one of the preceding claims, wherein A− is selected from chloride, bromide, iodide, hydroxide, sulfate, bisulfate, sulfamate, nitrate, phosphate, citrate, methanesulfonate, trifluoroacetate, glutamate, glucuronate, glutarate, malate, maleate, succinate, fumarate, tartrate, tosylate, salicylate, lactate, naphthalenesulfonate, and acetate.
The compound of any one of the preceding claims, wherein A− is selected from bromide, chloride, and hydroxide.
An empty lipid nanoparticle (empty LNP) comprising a cationic lipid of any one of the preceding claims.
A loaded LNP comprising:
- (a) a loaded LNP core comprising:
- (i) an ionizable lipid,
- (ii) a phospholipid,
- (iii) a structural lipid, and
- (iv) a PEG-lipid, and
- (b) a therapeutic and/or prophylactic agent encapsulated within the core for delivery into a cell, and
- (c) a cationic agent.
Dependencies are inferred from the claim text.